Results 11 to 20 of about 619,572 (261)

Adverse Events of DOACs in Children

Frontiers in Pediatrics, 2022
Venous thromboembolism (VTE) has an increasing rate of significance in pediatric patients. The currently standardized anticoagulants (unfractionated heparin, low molecular weight heparin and vitamin K antagonists) and their dose regimens were not ...
Alessandra Bosch, Manuela Albisetti, Manuela Albisetti   +2 more
doaj   +1 more source

Adverse events following vaccination against coronavirus disease 2019 [PDF]

Kosin Medical Journal, 2022
To overcome the coronavirus disease 2019 (COVID-19) pandemic, large-scale vaccination is proceeding worldwide. As of December 23, 2021, 10 novel vaccines against COVID-19 had been validated for use by the World Health Organization (WHO), including ...
Minji Jeon, Sol Jin, Jin-Young Lee
doaj   +1 more source

The prevalence of adverse drug event-related admissions at a local hospital in Malaysia

Archives of Pharmacy Practice, 2013
Aims: To determine the prevalence of adverse drug event (ADE)-related admissions and the related drugs. Setting and Designs: This study was conducted prospectively in two medical wards in Malaysia.
Mahmathi Karuppannan, Ting Kang Nee, Salmiah Mohd Ali, Wong Kok Thong, Helen Boardman   +4 more
doaj   +1 more source

Preventable adverse drug events in critically ill HIV patients: Is the detection of potential drug-drug interactions a useful tool?

Clinics, 2018
OBJECTIVES: The aim of this study was to develop a strategy to identify adverse drug events associated with drug-drug interactions by analyzing the prescriptions of critically ill patients.
Grazielle Viana Ramos, André Miguel Japiassú, Fernando Augusto Bozza, Lusiele Guaraldo   +3 more
doaj   +1 more source

Evidex

Journal of the Medical Library Association, 2019
Advera Health Analytics launched Evidex in 2016. The database provides information on drug safety and adverse events.
Meghan A. Hupe
doaj   +1 more source

Identifying barriers to report adverse drug reactions using the Delphi method: Experience from an institute of national importance of India

Perspectives in Clinical Research, 2022
Background: Spontaneous reporting of suspected adverse drug reaction (ADR) is an essential component of pharmacovigilance program, however, under reporting is a major drawback of it.
Bikash Ranjan Meher, Rashmi Ranjan Mohanty   +1 more
doaj   +1 more source

The burden of adverse drug events [PDF]

British Journal of Clinical Pharmacology, 2015
Drug safety should be considered as part of the balance between benefit and risk, and represents a burden to the patient, the healthcare professional, the regulator and industry. Each of these has a different view on adverse drug reactions and these are discussed in this article.
openaire   +2 more sources

A real-world pharmacovigilance study of the FAERS database for fluvoxamine: perspectives from physicians and pharmacists [PDF]

Brazilian Journal of Psychiatry
Objective: Although fluvoxamine is a well-established treatment for depressive disorders, real-world safety data remain limited. This study analyzed adverse drug events associated with fluvoxamine in the U.S. Food and Drug Administration’s Adverse Event
Weiming Xie, Na Li, Jun Gu, Fei Wang, Liang Liu, Jianhong Wu, Haifeng Wang   +6 more
doaj   +2 more sources

Corrigendum: Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database [PDF]

Frontiers in Pharmacology
Xi-Feng Wang, Lu-Ri Bao, Ta-La Hu, Rui-Feng Xu, Wu-Niri Gao, Jing-Yuan Wang, Jian-Rong Zhao, Zhen-Li Fu, Shu-Fang Wang, Yan Meng   +9 more
doaj   +2 more sources

Dentistry and Drug Adverse Events: Between Responsibilities and Regulations

Toxics, 2022
The purpose of this paper is to renew interest and attention to the medical history, prescription, and/or use of drugs during dental practice. The work analyzes the issue of the use of drugs in dentistry from both a clinical and a medical–legal point of ...
Tommaso D’Anna, Antonina Argo, Stefania Zerbo, Diego D’Urso, Maria Sofia Rini   +4 more
doaj   +1 more source